Registration for ASGCT's 28th Annual Meeting is NOW OPEN! Join us May 13-17 in New Orleans for the premier event in CGT.
Opportunities and resources for editorial staff
The American Society of Gene & Cell Therapy is the primary professional membership organization for gene and cell therapy. The Society's members are scientists, physicians, patient advocates, and other professionals.
The mission of ASGCT is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease.
The ASGCT Annual Meeting is the largest gathering of cell and gene therapy professionals. Save the dates to join us May 13-17, 2025, in New Orleans! Editorial staff get free registration and early access to 1,500+ abstracts with the latest research in gene and cell therapy.
Learn more about the Annual Meeting
Learn more aboout upcoming ASGCT events
Created in partnership with Informa Pharma Intelligence, this is the only field-wide report covering the therapeutics pipeline, clinical targets, developer progress, and more.
Learn about:
View all landscape reports
ASGCT's leaders are experts in:
The Society advocates for its members' and patients' needs through legislative meetings, liaising with the FDA, and publishing policy statements and letters.
Read policy statements and research
ASGCT's award-winning free Patient Education site provides scientific, reliable information for patients and the public. Expert members review and update all content.
View clear and accessible resources on topics such as gene therapy 101 and disease treatments.
Access educational resources
Access ASGCT's curated list of CGT trials sourced from clinicaltrials.gov. You can filter by location, diagnosis, treatment modality, or enrollment status.
Search for clinical trials
ASGCT is working to foster improved access to gene and cell therapies on a global scale. As part of these efforts, the Society has initiated partnered educational programming to support clinical development in middle-income countries.
In 2023, ASGCT was recognized for its global impact on gene therapy education in sub-Saharan Africa. The Global Gene Therapy Training course received a Gold Award from the American Society of Association Executives (ASAE).
Learn about ASGCT's global outreach iniatives
ASGCT focuses on diversity, equity, and inclusion efforts that benefit the future and current members of the Society and the communities they serve. Underrepresented groups and individuals within the bio-medical field are essential for scientific and technological innovations. Our goal is to increase awareness and opportunities for education.
In 2022 and 2023, ASGCT led an innovative program to provide Milwaukee teachers with curriculum training and lab equipment so they can bring biotechnology experiments into their classrooms, thanks to a generous grant from Bristol Myers Squibb.
Learn about ASGCT's DEI initiatives
January 22-23, 2025 | Virtual
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico